HYPERION DEFI, INC. (HYPD): Nasdaq/NYSE listing notice — Eyenovia receives Nasdaq deficiency notice for equity below $2.5M minimum

HYPERION DEFI, INC.

Nasdaq notified Eyenovia that stockholders' equity as of Dec 31, 2024 was below the $2.5M minimum required.
Company has 45 days (until June 13, 2025) to submit a compliance plan to Nasdaq.
If plan accepted, Nasdaq may grant up to 180 days (until Oct 26, 2025) to regain compliance.
Company intends to submit a plan; stock continues trading on Nasdaq under EYEN.
Failure to regain compliance could lead to delisting from Nasdaq Capital Market.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.96

HYPERION DEFI, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

April 29, 2025, Eyenovia, Inc. (the “Company”) received a notice (the “Notice”) from the staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s stockholders’ equity as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 was below the minimum $2,500,000 required for continued listing under Listing Rule 5550(b)(1) (the “Minimum Equity Requirement”). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market, which continues to trade under the symbol “EYEN”. In accordance with

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

HYPERION DEFI, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-044223

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.